Pharmacology

Action Mechanism of Action Reference
INHIBITOR Complement C5 inhibitor PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Hemoglobinuria, Paroxysmal 3 D006457 ClinicalTrials
Atypical Hemolytic Uremic Syndrome 3 D065766 ClinicalTrials
Anemia, Sickle Cell 1 D000755 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4594316
FDA SRS H9KH1GP3UU